The serum concentration of 1,25-dihydroxylvitamin D (1,25-[OH]2D) in normal children and in children with inherited diseases of bone was compared by use of a competitive binding assay. Observed values were: in 12 normal children and adolescents, 37.1 +/- 1.9 pg per milliliter (mean +/- S.D.); in 14 patients with X-linked hypophosphatemic rickets treated with vitamin D2 and phosphate supplements, 15.6 +/- 7.8 (P less than 0.01 versus control); in six patients with autosomal recessive vitamin D dependency treated with vitamin D2, 9.5 +/- 2.9 (P less than 0.01 versus control); and in four untreated patients with autosomal dominant hypophosphatemic (non-rachitic) bone disease, 30.2 +/- 6.3 (not significantly different from the controls). The difference in bone disease between X-linked hypophosphatemia (severe) and hypophosphatemic bone disease (mild) at comparable low serum levels of phosphate implies that 1,25-(OH)2D and phosphate may have independent roles in the pathogenesis of defective bone mineralization.
This article has been cited by other articles:
Kim, C. J., Kaplan, L. E., Perwad, F., Huang, N., Sharma, A., Choi, Y., Miller, W. L., Portale, A. A.
(2007). Vitamin D 1{alpha}-Hydroxylase Gene Mutations in Patients with 1{alpha}-Hydroxylase Deficiency. J. Clin. Endocrinol. Metab.
92: 3177-3182
[Abstract][Full Text]
Baum, M., Moe, O. W., Zhang, J., Dwarakanath, V., Quigley, R.
(2005). Phosphatonin washout in Hyp mice proximal tubules: evidence for posttranscriptional regulation. Am. J. Physiol. Renal Physiol.
288: F363-F370
[Abstract][Full Text]
Baum, M., Loleh, S., Saini, N., Seikaly, M., Dwarakanath, V., Quigley, R.
(2003). Correction of proximal tubule phosphate transport defect in Hyp mice in vivo and in vitro with indomethacin. Proc. Natl. Acad. Sci. USA
100: 11098-11103
[Abstract][Full Text]
Azam, N., Zhang, M. Y. H., Wang, X., Tenenhouse, H. S., Portale, A. A.
(2003). Disordered Regulation of Renal 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Gene Expression by Phosphorus in X-Linked Hypophosphatemic (Hyp) Mice. Endocrinology
144: 3463-3468
[Abstract][Full Text]
Wang, X., Zhang, M. Y. H., Miller, W. L., Portale, A. A.
(2002). Novel Gene Mutations in Patients with 1{alpha}-Hydroxylase Deficiency That Confer Partial Enzyme Activity in Vitro. J. Clin. Endocrinol. Metab.
87: 2424-2430
[Abstract][Full Text]
Dardenne, O., Prud'homme, J., Arabian, A., Glorieux, F. H., St-Arnaud, R.
(2001). Targeted Inactivation of the 25-Hydroxyvitamin D3-1{{alpha}}-Hydroxylase Gene (CYP27B1) Creates an Animal Model of Pseudovitamin D-Deficiency Rickets. Endocrinology
142: 3135-3141
[Abstract][Full Text]
Kitanaka, S., Murayama, A., Sakaki, T., Inouye, K., Seino, Y., Fukumoto, S., Shima, M., Yukizane, S., Takayanagi, M., Niimi, H., Takeyama, K.-i., Kato, S.
(1999). No Enzyme Activity of 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Gene Product in Pseudovitamin D Deficiency Rickets, Including That with Mild Clinical Manifestation. J. Clin. Endocrinol. Metab.
84: 4111-4117
[Abstract][Full Text]
Kitanaka, S., Takeyama, K.-i., Murayama, A., Sato, T., Okumura, K., Nogami, M., Hasegawa, Y., Niimi, H., Yanagisawa, J., Tanaka, T., Kato, S.
(1998). Inactivating Mutations in the 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Gene in Patients with Pseudovitamin D-Deficiency Rickets. NEJM
338: 653-662
[Abstract][Full Text]
Brenza, H. L., Kimmel-Jehan, C., Jehan, F., Shinki, T., Wakino, S., Anazawa, H., Suda, T., DeLuca, H. F.
(1998). Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha -hydroxylase gene promoter. Proc. Natl. Acad. Sci. USA
95: 1387-1391
[Abstract][Full Text]
Fu, G. K., Lin, D., Zhang, M. Y. H., Bikle, D. D., Shackleton, C. H. L., Miller, W. L., Portale, A. A.
(1997). Cloning of Human 25-Hydroxyvitamin D-1{alpha}-Hydroxylase and Mutations Causing Vitamin D-Dependent Rickets Type 1. Mol. Endocrinol.
11: 1961-1970
[Abstract][Full Text]
Econs, M. J., Francis, F.
(1997). Positional cloning of the PEX gene: new insights into the pathophysiology of X-linked hypophosphatemic rickets. Am. J. Physiol. Renal Physiol.
273: F489-F498
[Abstract][Full Text]
Nehgme, R., Fahey, J. T., Smith, C., Carpenter, T. O.
(1997). Cardiovascular Abnormalities in Patients with X-Linked Hypophosphatemia. J. Clin. Endocrinol. Metab.
82: 2450-2454
[Abstract][Full Text]
Econs, M. J., McEnery, P. T.
(1997). Autosomal Dominant Hypophosphatemic Rickets/Osteomalacia: Clinical Characterization of a Novel Renal Phosphate-Wasting Disorder. J. Clin. Endocrinol. Metab.
82: 674-681
[Abstract][Full Text]
Shah, B. R., Fiordalisi, I., Sheinbaum, K., Finberg, L.
(1988). Familial Glucocorticoid Deficiency in a Girl With Familial Hypophosphatemic Rickets. Arch Pediatr Adolesc Med
142: 900-903
[Abstract]
Mason, R. S., Rohl, P. G., Lissner, D., Posen, S.
(1982). Vitamin D Metabolism in Hypophosphatemic Rickets. Arch Pediatr Adolesc Med
136: 909-913
[Abstract]
Chesney, R. W., Hamstra, A. J., DeLuca, H. F.
(1981). Rickets of Prematurity: Supranormal Levels of Serum 1,25-Dihydroxyvitamin D. Arch Pediatr Adolesc Med
135: 34-37
[Abstract]
Chesney, R. W., Rosen, J. F., Hamstra, A. J., DeLuca, H. F.
(1980). Serum 1,25-Dihydroxyvitamin D Levels in Normal Children and in Vitamin D Disorders. Arch Pediatr Adolesc Med
134: 135-139
[Abstract]
Chesney, R. W., Mazess, R. B., Rose, P., Hamstra, A. J., DeLuca, H. F.
(1980). Supranormal 25-Hydroxyvitamin D and Subnormal 1,25-Dihydroxyvitamin D: Their Role in X-linked Hypophosphatemic Rickets. Arch Pediatr Adolesc Med
134: 140-143
[Abstract]
Previous
